Systemic mastocytosis with associated myeloproliferative neoplasm with t(8;19)(p12;q13.1) and abnormality of FGFR1: Report of a unique case

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 2, 2014, Pages 801-807

  Duckworth, Christina B ^a   Zhang, Linsheng ^a   Li, Shiyong ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Eosinophilia; FGFR1; Myeloproliferative neoplasm; Systemic mastocytosis associated with clonal hematological non mast cell lineage disease

Indexed keywords

FGFR1 PROTEIN, HUMAN; FIBROBLAST GROWTH FACTOR RECEPTOR 1; TUMOR MARKER;

AGED; ARTICLE; BIOPSY; BONE MARROW EXAMINATION; CASE REPORT; CHROMOSOME 19; CHROMOSOME 8; EOSINOPHILIA; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; GENE TRANSLOCATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KARYOTYPING; MALE; METABOLISM; MYELOPROLIFERATIVE DISORDER; MYELOPROLIFERATIVE NEOPLASM; PATHOLOGY; PHENOTYPE; STEM CELL TRANSPLANTATION; SYSTEMIC MASTOCYTOSIS; SYSTEMIC MASTOCYTOSIS ASSOCIATED WITH CLONAL HEMATOLOGICAL NON-MAST CELL LINEAGE DISEASE; TREATMENT OUTCOME;

EOSINOPHILIA; FGFR1; MYELOPROLIFERATIVE NEOPLASM; SYSTEMIC MASTOCYTOSIS ASSOCIATED WITH CLONAL HEMATOLOGICAL NON-MAST CELL LINEAGE DISEASE;

AGED; BIOPSY; BONE MARROW EXAMINATION; CHROMOSOMES, HUMAN, PAIR 19; CHROMOSOMES, HUMAN, PAIR 8; GENE REARRANGEMENT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; MALE; MASTOCYTOSIS, SYSTEMIC; MYELOPROLIFERATIVE DISORDERS; PHENOTYPE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; STEM CELL TRANSPLANTATION; TRANSLOCATION, GENETIC; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84907759689     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Horny HP, Bennett JM, Bain BJ. Mastocytosis. In: Swerdlow SH, Harris NL, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th edition. Lyon, France: IARC press 2008; pp: 54-63
2. Pardanani A, Lim KH, Lasho TL, Finke C, McClure RF, Li CY, Tefferi T. Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies. Blood 2009; 114: 3769-72
3. Lim KH, Tefferi A, Lasho TL, Finke C, Patnaik M, Butterfield JH, McClure RF, Li CY, Pardanani A. Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors. Blood 2009; 113: 5727-36
4. Bain BJ, Horny HP, Vardiman JW. Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1. In: Swerdlow SH, Harris NL, editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th edition. Lyon, France: IARC Press 2008; pp: 68-78
5. Jackson CC, Medeiros LJ and Miranda RN. 8p11 myeloproliferative syndrome: a review. Hum Pathol 2010; 41: 461-76
6. Martinez-Climent JA, Vizcarra E, Benet I, Marugan I, Terol MJ, Solano C, Arbona C, Tormo M, Comes AM, Garcia-Conde J. Cytogenetic response induced by interferon alpha in the myeloproliferative disorder with eosinophilia, T cell lymphoma and the chromosomal translocation t(8;13)(p11;q12). Leukemia 1998; 12: 999-1000
7. Chen J, Deangelo DJ, Kutok JL, Williams IR, Lee BH, Wadleigh M, Duclos N, Cohen S, Adelsperger J, Okabe R, Coburn A, Galinsky I, Huntly B, Cohen PS, Meyer T, Fabbro D, Roesel J, Banerji L, Griffin JD, Xiao S, Fletcher JA, Stone RM, Gilliland DG. PKC412 inhibits the zinc finger 198-fibroblast growth factor receptor 1 fusion tyrosine kinase and is active in treatment of stem cell myeloproliferative disorder. Proc Natl Acad Sci U S A 2004; 101: 14479-84
8. Kim SY, Oh B, She CJ, Kim HK, Jeon YK, Shin MG, Yoon SS, Lee DS. 8p11 Myeloproliferative syndrome with BCR-FGFR1 rearrangement presenting with T-lymphoblastic lymphoma and bone marrow stromal cell proliferation: a case report and review of the literature. Leuk Res 2011; 35: e30-4
9. Wakim JJ, Tirado CA, Chen W, Collins R. t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature. Leuk Res 2011; 35: e151-3
10. Onozawa M, Ohmura K, Ibata M, Iwasaki J, Okada K, Kasahara I, Yamaguchi K, Kubota K, Fujisawa S, Shigematsu A, Endo T, Kondo T, Hashino S, Tanaka J, Matsuno Y, Asaka M, Imamura M. The 8p11 myeloproliferative syndrome owing to rare FGFR1OP2-FGFR1 fusion. Eur J Haematol 2011; 86: 347-9
11. Hu S, He Y, Zhu X, Li J, He H. Myeloproliferative disorders with t(8;9)(p12;q33): a case report and review of the literature. Pediatr Hematol Oncol 2011; 28: 140-6
12. Patnaik MM, Gangat N, Knudson RA, Keefe JG, Hanson CA, Pardanani A, Ketterling RP, Tefferi A. Chromosome 8p11.2 translocations: prevalence, FISH analysis for FGFR1 and MYST3, and clinicopathologic correlates in a consecutive cohort of 13 cases from a single institution. Am J Hematol 2010; 85: 238-42
13. Chen X, Zhang Y, Li Y, Lei P, Zhai Y, Liu L. Biphenotypic hematologic malignancy: a case report of the 8p11 myeloproliferative syndrome in a child. J Pediatr Hematol Oncol 2010; 32: 501-3
14. Baldazzi C, Iacobucci I, Luatti S, Ottaviani E, Marzocchi G, Paolini S, Stacchini M, Papayannidis C, Gamberini C, Martinelli G, Baccarani M, Testoni N. B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene. Leuk Res 2010; 34: e282-5
15. Mugneret F, Chaffanet M, Maynadie M, Guasch G, Favre B, Casasnovas O, Birnbaum D, Pebusque MJ. The 8p12 myeloproliferative disorder. t(8;19)(p12;q13.3): a novel translocation involving the FGFR1 gene. Br J Haematol 2000; 111: 647-9
16. Guasch G, Popovici C, Mugneret F, Chaffanet M, Pontarotti P, Birnbaum D, Pebusque MJ. Endogenous retroviral sequence is fused to FGFR1 kinase in the 8p12 stem-cell myeloproliferative disorder with t(8;19)(p12;q13.3). Blood 2003; 101: 286-8
17. Gervais C, Dano L, Perrusson N, Helias C, Jeandidier E, Galoisy AC, Ittel A, Herbrecht R, Bilger K, Mauvieux L. A translocation t(2;8)(q12;p11) fuses FGFR1 to a novel partner gene, RANBP2/NUP358, in a myeloproliferative/myelodysplastic neoplasm. Leukemia 2013; 27: 1186-8
18. Li F, Zhai YP, Tang YM, Wang LP, Wan PJ. Identification of a novel partner gene, TPR, fused to FGFR1 in 8p11 myeloproliferative syndrome. Genes Chromosomes Cancer 2012; 51: 890-7
19. Lee H, Kim M, Lim J, Kim Y, Han K, Cho BS, Kim HJ. Acute myeloid leukemia associated with FGFR1 abnormalities. Int J Hematol 2013; 97: 808-12
20. Ollendorff V, Guasch G, Isnardon D, Galindo R, Birnbaum D, Pebusque MJ. Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation. J Biol Chem 1999; 274: 26922-30
21. Guasch G, Mack GJ, Popovici C, Dastugue N, Birnbaum D, Rattner JB, Pebusque MJ. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33). Blood 2000; 95: 1788-96
22. Guasch G, Ollendorff V, Borg JP, Birnbaum D, Pebusque MJ. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways. Mol Cell Biol 2001; 21: 8129-42
23. Demiroglu A, Steer EJ, Heath C, Taylor K, Bentley M, Allen SL, Koduru P, Brody JP, Hawson G, Rodwell R, Doody ML, Carnicero F, Reiter A, Goldman JM, Melo JV, Cross NC. The t(8;22) in chronic myeloid leukemia fuses BCR to FGFR1: transforming activity and specific inhibition of FGFR1 fusion proteins. Blood 2001; 98: 3778-83
24. Agerstam H, Jaras M, Andersson A, Johnels P, Hansen N, Lassen C, Rissler M, Gisselsson D, Olofsson T, Richter J, Fan X, Ehinger M, Fioretos T. Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice. Blood 2010; 116: 2103-11
25. Ren M, Cowell JK. Constitutive Notch pathway activation in murine ZMYM2-FGFR1-induced T-cell lymphomas associated with atypical myeloproliferative disease. Blood 2011; 117: 6837-47
26. Lewis JP, Welborn JL, Meyers FJ, Levy NB, Roschak T. Mast cell disease followed by leukemia with clonal evolution. Leuk Res 1987; 11: 769-73
27. Mayeur-Rousse C, Sorel N, Voldoire M, Canioni D, Brizard F, Randriamalala E, Turhan AG, Chomel JC. Unique association of systemic mastocytosis and myeloid/lymphoid neoplasm in blast crisis with abnormality of FGFR1 gene. Leuk Res 2012; 36: 377-81